Position in RPRX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$21,521,852
+$1,980,362 QoQ
Shares Held
383,839
-5.8% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#8
of 107 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026River Road Asset Management, LLC holds $52,591,739 across 2 Biotechnology names. RPRX ranks #2 (40.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
542,990 | $31,069,887 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
383,839 | $21,521,852 |
All Filings in RPRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,521,852 | 383,839 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $19,541,490 | 407,369 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $20,040,790 | 518,654 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $19,016,378 | 539,013 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,608,030 | 544,214 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,232,169 | 457,185 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,186,729 | 399,323 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $13,295,734 | 469,980 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $11,287,994 | 428,062 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $13,435,080 | 442,380 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $4,343,809 | 154,639 | Shares | Sole | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||